[Pyridostigmine bromide therapy of the adrenergic phase of postoperative disease].
D018663:Adrenergic Agents; D005260:Female; D006801:Humans; D010277:Parasympathomimetics / Q000627:therapeutic use*; D011729:Pyridostigmine Bromide; D013514:Surgical Procedures, Operative / Q000150:complications*
D018663:Adrenergic Agents; D010277:Parasympathomimetics; D011729:Pyridostigmine Bromide
PARASYMPATHOMIMETICS/therapeutic use; SURGERY, OPERATIVE/complications
Il trattamento della fase adrenergica della malattia postoperatoria con il bromuro di piridostigmina.